-
LIV cash crunch hits Asian Tour as Korea Open prize money cut
-
'Wiped out': Ukraine's bird lovers long for peaceful skies
-
Union calls strike at South Korea chip giant Samsung Electronics
-
Putin, Xi hail 'unyielding' ties in talks after Trump visit
-
Director Boots Riley says new film 'I Love Boosters' is an 'optimistic' satire
-
Sky bridges, citizen science protect endangered Malaysia monkeys
-
Elephant in the room: Nepal's first Cannes film takes on taboos
-
Pentagon says it has reduced brigades in Europe from four to three
-
Union calls strike at S. Korea chip giant Samsung Electronics
-
Knicks rally from 22 points down to stun Cavs in NBA East finals opener
-
Eala and Tjen bring a Southeast Asian 'sense of pride' to Roland Garros
-
Djokovic trying to hold back time at French Open
-
How are the World Cup favourites shaping up?
-
Taiwan leader says 'foreign forces' cannot decide island's future
-
Knicks rally to stun Cavs in overtime in NBA Eastern Conference finals opener
-
Pressure mounts at United Nations for climate change 'lifeline'
-
Cubans want change, but not at gunpoint
-
Asia stocks slide on inflation fears as yields surge
-
Putin, Xi to underscore alliance strength after Trump visit
-
Help wanted: Australian conservation group seeks new koala rescue dog
-
Musk's empire as SpaceX counts down to Wall Street liftoff
-
SpaceX's IPO moonshot draws some doubters on Wall Street
-
Under Trump pressure, EU agrees to implement US trade pact
-
Republican who stood up to Trump defeated in Kentucky primary
-
Acting US attorney general defends fund for prosecuted Trump allies
-
Mavericks part ways with head coach Kidd
-
Shock and bafflement at San Diego mosque where three were killed
-
US enforces law to crack down on sexual deepfakes
-
Arsenal crowned Premier League champions after Man City draw
-
New York art auctions roar back with blockbuster sales
-
US says held talks with Cuba on $100 mln offer
-
Chelsea beat Spurs to leave rivals in 'embarrassing' relegation danger
-
Google wants its search bar to act on your behalf in AI revamp
-
Taiwan author wins International Booker for 'slyly sophisticated' novel
-
Iran 'very confident' about World Cup protocols: federation vice-president
-
Google unveils smart glasses, taking on Meta
-
Guardiola swerves Man City exit talk as title hopes ended
-
Chiefs' Rice jailed for probation violation
-
Five factors in Arsenal's Premier League title triumph
-
Mikel Arteta: Pep protege to Premier League winner
-
How Arsenal banished 'nearly men' tag to end 22-year title wait
-
Arsenal win Premier League after Man City held by Bournemouth
-
From graduation boos to voter unease: AI anxiety grows in the US
-
Lost in Trump's climate boast: best-case scenario abandoned
-
Hantavirus cruise operator says ship not source of outbreak
-
Trump shows off ballroom site with 'drone empire' planned for roof
-
Rubio to attend NATO talks, pay first visit to India
-
Under Trump pressure, EU seeks deal to end trade standoff
-
Airbus seeks to cut peripheral expenses due to Mideast war
-
France encourages women to report rape in probes of star Bruel
US Supreme Court rejects bid to restrict abortion pill
The US Supreme Court on Thursday rejected a bid to restrict an abortion pill widely used in the United States to terminate pregnancies.
The court, in a unanimous opinion, said the anti-abortion groups and physicians challenging the medication, mifepristone, lacked the legal standing to bring the case.
Abortion rights are one of the key issues in the November election and the administration of Democratic President Joe Biden had urged the court to maintain access to the drug, which was approved by the Food and Drug Administration (FDA) in 2000. His opponent Donald Trump leads a Republican Party broadly favoring blocks to abortion access.
The mifepristone case was the first significant abortion case heard by the conservative-dominated Supreme Court since it overturned the previously long-held constitutional right to abortion two years ago.
"We recognize that many citizens, including the plaintiff doctors here, have sincere concerns about and objections to others using mifepristone and obtaining abortions," said Justice Brett Kavanaugh, who wrote the 9-0 opinion.
"But citizens and doctors do not have standing to sue simply because others are allowed to engage in certain activities," Kavanaugh said. "The plaintiffs lack standing to challenge FDA's actions."
The conservative justice said the federal courts were "the wrong forum for addressing the plaintiffs' concerns about FDA's actions" and they could present their objections through regulatory procedures or through the "political and electoral processes."
Abortion opponents have been seeking to restrict nationwide access to the pill, claiming it is unsafe and that anti-abortion doctors were being forced to violate their conscience by intervening on patients who suffered complications after using it.
A conservative US district court judge in Texas, who was appointed during Trump's presidency, issued a ruling last year that would have banned mifepristone.
An appeals court overturned the outright ban because the statute of limitations on challenging the FDA's approval had expired, but restricted access to the drug.
The appeals court reduced the period during which mifepristone can be used from 10 weeks of pregnancy to seven weeks, blocked it from being delivered by mail, and required the pill to be prescribed and administered by a doctor.
The Supreme Court ruling lifts those restrictions.
Medication abortion accounted for 63 percent of the abortions in the country last year, up from 53 percent in 2020, according to the Guttmacher Institute.
Some 20 states have banned or restricted abortion since the Supreme Court in June 2022 overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century.
Polls show a majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure or ban it outright.
N.Shalabi--SF-PST